Glooko
Palo Alto, US · Founded 2010 · Delaware corporation · 236 employees on LinkedIn · 3 known investors
Find your way into Glooko
462 people in our graph share verified history with the Glooko team — schools, employers, funds. One of them is your warm intro.
Glooko operates a cloud-connected diabetes management platform that automatically syncs data from CGMs and insulin pumps into care teams' clinical workflows for in-office and remote patient monitoring. It serves healthcare providers and clinics managing people with diabetes, integrating with device makers such as Abbott, Dexcom, Insulet, and Tandem, and with EHR systems including Epic and Oracle Health.
Founders & leadership









Board


Investors · 3
Reported raises · per SEC filings
Form D private placements$30M disclosed across 1 of 3 rounds · 2021–2024
▶$124MofferedAug 2024 · Other Health CareRule 506(b)
- Clay DavidsonExecutive Officer
- Prakash MenonExecutive Officer
- Wende HuttonDirector
- Ed MarshallExecutive Officer
- David PassExecutive Officer
- Charles BooradyDirector
- Adam HameedExecutive Officer
- Mark BeuclerExecutive Officer
- Simon ChongDirector
- Enrique ConternoDirector
- Russ JohannessonExecutive Officer
- Tracy BahlDirector
- Offering amount
- $124M
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$67MofferedAug 2023 · Other Health CareRule 506(b)
- Charles BooradyDirector
- Komathi StemExecutive Officer
- Steve LienExecutive Officer
- Ed MarshallExecutive Officer
- Tracy BahlDirector
- Christina DickersonExecutive Officer
- Alfonso ZuluetaDirector
- Clay DavidsonExecutive Officer
- Yogen DalalDirector
- Simon ChongDirector
- Prakash MenonExecutive Officer
- Wende HuttonDirector
- Russ JohannessonExecutive Officer, Director
- Offering amount
- $67M
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$30MraisedMar 2021 · 11 investors · Other Health CareRule 506(b)
- Yogen DalalDirector
- Zach HendersonExecutive Officer
- Steve LienExecutive Officer
- Russ JohannessonExecutive Officer, Director
- Clay DavidsonExecutive Officer
- Komathi SternExecutive Officer
- Charles BooradyDirector
- Mike DohertyDirector
- Simon ChongDirector
- Wende HuttonDirector
- Offering amount
- $35M
- Amount sold
- $30M
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapCompanies competing with Glooko for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Glooko do?
- Glooko operates a cloud-connected diabetes management platform that automatically syncs data from CGMs and insulin pumps into care teams' clinical workflows for in-office and remote patient monitoring. It serves healthcare providers and clinics managing people with diabetes, integrating with device makers such as Abbott, Dexcom, Insulet, and Tandem, and with EHR systems including Epic and Oracle Health.
- Who are Glooko's investors?
- Glooko's investors include Canaan Partners, Health Catalyst Capital, Samsung Next.
- How much funding has Glooko raised?
- Glooko has disclosed $30M raised across 1 of its 3 known rounds.
- Where is Glooko headquartered?
- Glooko is headquartered in Palo Alto, US.



